Image_2_Trans ε-Viniferin Decreases Amyloid Deposits With Greater Efficiency Than Resveratrol in an Alzheimer’s Mouse Model.pdf by Aline Freyssin (11912204)

“…Furthermore, a significant decrease in brain uptake of the TSPO PET tracer [¹⁸F]DPA-714 was observed with viniferin compared to resveratrol. …”

Table_2_Trans ε-Viniferin Decreases Amyloid Deposits With Greater Efficiency Than Resveratrol in an Alzheimer’s Mouse Model.pdf by Aline Freyssin (11912204)

“…Furthermore, a significant decrease in brain uptake of the TSPO PET tracer [¹⁸F]DPA-714 was observed with viniferin compared to resveratrol. …”

Image_4_Trans ε-Viniferin Decreases Amyloid Deposits With Greater Efficiency Than Resveratrol in an Alzheimer’s Mouse Model.pdf by Aline Freyssin (11912204)

“…Furthermore, a significant decrease in brain uptake of the TSPO PET tracer [¹⁸F]DPA-714 was observed with viniferin compared to resveratrol. …”

As compared to HD, RRMS and T1D patients show significantly greater preponderance of rs2281808 CT/TT carriers. by Sushmita Sinha (348580)

<i>Kpna1</i> KO mice show decreased anxiety-like behavior in the elevated plus maze. by Koki Sakurai (11690201)

Subjects:

Ethnic identity as a moderator among APIDA students. by Ronna Bañada (19233063)

Subjects:

Regression models of COVID-19-related racial discrimination and depression symptoms among the full sample. by Ronna Bañada (19233063)

Subjects:

A comparison of the primary outcome, HbA1c, throughout the 6-month follow-up. by Wenwen Yin (1877125)

Subjects:

Table 1_Food scarcity and decrease in income are associated with depression after COVID-19 pandemic in rural settings.docx by Dharmendra Gahwai (20987825)

Behaviors with a significant main effect or interaction. by Grace Hecker (18813445)

Subjects:

Effects of Roflumilast on hippocampal levels of: (A) IL6, (B) dopamine and (C) cortisone in Depressed Adult Male Wistar Rats (n = 10)a: P<0.05 versus control group, b: P<0.05 versu... by Ghida Hassan (17904169)

Subjects:

Data_Sheet_1_Decreased plasma neuropeptides in first-episode schizophrenia, bipolar disorder, major depressive disorder: associations with clinical symptoms and cognitive function.... by Hua Yu (138267)

“…We additionally measured cognitive function by using a battery of tests given to all participants.</p>Results<p>α-MSH, neurotensin, orexin-A, oxytocin, and substance P were decreased in the three patient groups compared with controls. …”

Table_1_Childhood Maltreatment Was Correlated With the Decreased Cortical Function in Depressed Patients Under Social Stress in a Working Memory Task: A Pilot Study.DOCX by Mengying Ma (3092703)

“…<p>Background: Major depressive disorder (MDD) is a common psychiatric disorder associated with working memory (WM) impairment. …”

Change in Watt’s Connectedness Scale, Subscales by Treatment Group. by Benjamin R. Lewis (22279166)

Subjects:

Primary and secondary efficacy end points (intention-to-treat population). by Benjamin R. Lewis (22279166)

Subjects:

Demographic and clinical characteristics of participants at baseline. by Benjamin R. Lewis (22279166)

Subjects:

Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group. by Benjamin R. Lewis (22279166)

Subjects:

Change in Demoralization Scale (DSII) by Treatment Group. by Benjamin R. Lewis (22279166)

Subjects:

Change in Watt’s Connectedness Scale (WCS), General Connectedness by Treatment Group. by Benjamin R. Lewis (22279166)

Subjects:

High postpartum maternal depression, stress, and morning cortisol concentration significantly decrease Shannon’s Entropy in infant stool. by Johanna R. Jahnke (10833803)